查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566940

生物相容性涂料市场：按类型、材料和最终用户划分：2024-2033 年全球机会分析和产业预测

Biocompatible Coating Market By Type (Antimicrobial, Hydrophilic, Others) , By Material (Polymer, Ceramic, Metal, Others) By End User (Healthcare, Medical Device, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年生物相容性涂料市场价值为134亿美元，预计2024年至2033年复合年增长率为12%，到2033年达到414亿美元。

生物相容性涂层是应用于医疗设备、植入和其他医疗保健相关材料的生物材料，以确保与人体生物环境的兼容性。这些涂层旨在促进设备与周围组织之间的和谐相互作用，从而最大限度地减少发炎和排斥等副作用。透过赋予耐腐蚀性、耐磨性和生物活性等特性来提高医疗植入的性能和寿命，对于推进医疗技术和改善患者治疗效果至关重要。

由于老年人口的迅速增长和慢性病患病率的上升，对整形外科、牙科和心血管设备等医疗植入的需求不断增长，推动了全球生物相容性涂料市场的增长，这些医疗植入需要生物相容性涂料来确保安全和安全。此外，对降低感染疾病和植入排斥等併发症风险的日益重视正在推动生物相容性涂层的采用，以提高医疗设备的安全性和相容性。此外，製药业的扩张和药物传输系统需求的激增需要生物相容性涂层来确保活性药物成分的控制释放和稳定性，从而促进市场成长。此外，开发具有抗菌特性的生物相容性涂层以降低与医疗植入和医疗设备相关的感染疾病风险的趋势也在显着推动市场成长。这些含有银离子和其他抗菌剂的涂层对于预防术后併发症至关重要。然而，生物相容性涂料的研发高成本，尤其是那些采用奈米技术和生物活性物质等先进材料的涂料，阻碍了市场的成长。这是由于开发兼俱生物相容性和耐用性的涂层存在技术困难。确保稳定的膜厚度、防止随时间劣化以及实现所需的功能特性等问题可能会限制某些涂层的扩充性和适用性。同时，医疗设备设计和製造的技术创新，例如微创手术的发展，正在推动对先进生物相容性涂层的需求，以提高这些设备的性能和耐用性。预计这些新兴市场的开拓将为预测期内的市场成长提供有利可图的机会。

全球生物相容性涂料产业按类型、材料、最终用户和地区细分。按类型划分，市场分为抗菌、亲水等。依材质分为聚合物、陶瓷、金属等。按最终使用者分为医疗保健、医疗设备和其他。按地区划分，对北美、欧洲、亚太地区和拉丁美洲地区市场进行了分析。

主要发现

按类型划分，抗菌涂料领域预计将在 2024 年至 2033 年期间主导全球市场。

从材料来看，聚合物预计将在预测期内成为主要部分。

从最终用户来看，医疗设备产业预计在未来几年将显着成长。

按地区划分，就 2023 年以收益为准，北美占据最大市场占有率，预计在预测期内也将主导市场。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介
  • 公司简介的扩充列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章生物相容性涂料市场：依类型

  • 市场概况
  • 抗菌的
  • 亲水性的
  • 其他的

第五章生物相容性涂料市场：依材料分类

  • 市场概况
  • 聚合物
  • 陶瓷製品
  • 金属
  • 其他的

第六章生物相容性涂料市场：依最终用户分类

  • 市场概况
  • 卫生保健
  • 医疗设备
  • 其他的

第七章生物相容性涂料市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国生物相容性涂料市场
    • 加拿大生物相容性涂料市场
    • 墨西哥生物相容性涂料市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国生物相容性涂料市场
    • 德国生物相容性涂料市场
    • 义大利生物相容性涂料市场
    • 西班牙生物相容性涂料市场
    • 英国生物相容性涂料市场
    • 其他欧洲国家生物相容性涂料市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国生物相容性涂料市场
    • 日本生物相容性涂料市场
    • 印度生物相容性涂料市场
    • 韩国生物相容性涂料市场
    • 澳洲生物相容性涂料市场
    • 其他亚太生物相容性涂料市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西生物相容性涂料市场
    • 南非生物相容性涂料市场
    • 沙乌地阿拉伯生物相容性涂料市场
    • 其他拉丁美洲/中东/非洲生物相容性涂料市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • DSM Biomedical BV
  • Surmodics, Inc.
  • BASF SE
  • Covalon Technologies Ltd.
  • Harland Medical Systems, LLC
  • Biocoat, Inc.
  • BioInteractions Ltd.
  • AST Products, Inc.
  • PPG Industries
  • Precision Coating Company, Inc.
简介目录
Product Code: A323973

The biocompatible coating market was valued at $13.4 billion in 2023, and is projected to reach $41.4 billion by 2033, growing at a CAGR of 12% from 2024 to 2033.

Biocompatible coatings are biomaterials that are applied to medical devices, implants, and other healthcare-related materials to ensure they are compatible with the biological environment of the human body. These coatings are designed to minimize adverse reactions, such as inflammation or rejection, by promoting a harmonious interaction between the device and surrounding tissues. They enhance the performance and longevity of medical implants by imparting properties like anti-corrosion, anti-wear, and bioactivity, making them essential in advancing medical technology and improving patient outcomes.

The growth of the global biocompatible coating market is driven by surge in geriatric population and rise in prevalence of chronic diseases that are leading to increased need for medical implants, such as orthopedic, dental, and cardiovascular devices, which require biocompatible coatings for safe and effective integration with the body. According to the 2022 American Joint Replacement Registry (AJRR) annual report, approximately 2.8 million hip and knee procedures were carried out in the U.S. Moreover, rise in emphasis on reducing the risk of complications, such as infections and implant rejection, is driving the adoption of biocompatible coatings that improve the safety and compatibility of medical devices. Furthermore, the expansion of the pharmaceutical sector and surge in demand for drug delivery systems, which require biocompatible coatings to ensure controlled release and stability of active pharmaceutical ingredients, contribute toward the market growth. Moreover, the growing trend toward developing biocompatible coatings with antimicrobial properties to reduce the risk of infections associated with medical implants and devices is significantly fostering the market growth. These coatings, incorporating silver ions or other antimicrobial agents, are crucial in preventing postoperative complications. However, high cost associated with R&D of biocompatible coatings, especially those incorporating advanced materials like nanotechnology or bioactive substances, hampers the market growth. This is attributed to the fact that developing coatings that are both biocompatible and durable is technically challenging. Issues such as ensuring consistent coating thickness, preventing degradation over time, and achieving the desired functional properties can limit the scalability and applicability of certain coatings. On the contrary, innovations in medical device design and manufacturing, including the development of minimally invasive procedures, are driving the demand for advanced biocompatible coatings that enhance the performance and durability of these devices. Such developments are expected to offer lucrative opportunities for the market growth during the forecast period.

The global biocompatible coating industry is segmented into type, material, end user, and region. On the basis of type, the market is fragmented into antimicrobial, hydrophilic, and others. Depending on material, it is divided into polymer, ceramic, metal, and others. As per end user, it is segregated into healthcare, medical device, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the antimicrobial coatings segment is expected to dominate the global market from 2024 to 2033.

Depending on material, polymers is anticipated to emerge as a leading segment during the forecast period.

As per end user, the medical device segment is projected to exhibit notable growth in the coming years.

Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global biocompatible coating market include DSM Biomedical B.V., Surmodics, Inc., BASF SE, Covalon Technologies Ltd., Harland Medical Systems, LLC, Biocoat, Inc., BioInteractions Ltd., AST Products, Inc., PPG Industries, and Precision Coating Company, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Antimicrobial
  • Hydrophilic
  • Others

By Material

  • Polymer
  • Ceramic
  • Metal
  • Others

By End User

  • Healthcare
  • Medical Device
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • DSM Biomedical B.V.
    • Surmodics, Inc.
    • BASF SE
    • Covalon Technologies Ltd.
    • Harland Medical Systems, LLC
    • Biocoat, Inc.
    • BioInteractions Ltd.
    • AST Products, Inc.
    • PPG Industries
    • Precision Coating Company, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOCOMPATIBLE COATING MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Antimicrobial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Hydrophilic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOCOMPATIBLE COATING MARKET, BY MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Material
  • 5.2. Polymer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ceramic
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Metal
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOCOMPATIBLE COATING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Medical Device
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOCOMPATIBLE COATING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Biocompatible Coating Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Biocompatible Coating Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Biocompatible Coating Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Biocompatible Coating Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Biocompatible Coating Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Biocompatible Coating Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Biocompatible Coating Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Biocompatible Coating Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Biocompatible Coating Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Biocompatible Coating Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Biocompatible Coating Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Biocompatible Coating Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Biocompatible Coating Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Biocompatible Coating Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Biocompatible Coating Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Biocompatible Coating Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Biocompatible Coating Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Biocompatible Coating Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Biocompatible Coating Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. DSM Biomedical B.V.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Surmodics, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BASF SE
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Covalon Technologies Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Harland Medical Systems, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Biocoat, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BioInteractions Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. AST Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PPG Industries
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Precision Coating Company, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments